CA
CLBT icon

Crewe Advisors’s Cellebrite CLBT Stock Holding History

Crewe Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.84K Hold
400
– – ﹤0.01% 850
2026
Q1 		$5.51K Hold
400
– – ﹤0.01% 761
2025
Q4 		$7.21K Hold
400
– – ﹤0.01% 677
2025
Q3 		$7.41K Buy
+400
New +$6.28K ﹤0.01% 678

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Crewe Advisors's CLBT Position: Q2 2026 in Review

Crewe Advisors held its Cellebrite (CLBT) position steady in Q2 2026 at 400 shares worth $5.84K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Crewe Advisors first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.41K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Crewe Advisors held 400 shares of Cellebrite worth $5.84K as of Q2 2026.
  • Crewe Advisors left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #850 holding.
  • Crewe Advisors first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • Crewe Advisors's Cellebrite position peaked at $7.41K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.